Consistently, studies in a humanized mouse model of lung cancer showed that IL-34-producing chemoresistant tumors exhibit increased numbers of M2-type TAMs and reduced frequencies of tumor-infiltrating cytotoxic CD8+ T cells [67]. Here, IL34 is linked to neoplasm.